Check-Cap, a Mount Camel, Israel-based medical device company that is developing an innovative imaging capsule that uses X-rays for early detection of pre-cancerous polyps and colon cancer, has completed a NIS35m private funding.
The company intends to use the funds to carry out a clinical trial of the imaging capsule on about 50 people, which is expected to begin later this year and to continue for about 6 months. Based on the results of the study, Check-Cap intends to submit an application for CE approval in Europe.
According to Check-Cap, the funds will be sufficient to take it through the application for approval of sales in Europe during the second half of 2012.
Led by CEO Guy Neev, the company is developing a capsule that utilizes an innovative technology, which is designed to enable early detection and diagnosis of precancerous tumors and colon cancer, without the need for bowel cleansing preparation,
The Check-Cap Imaging System enables early identification of precancerous tumors in the intestine by means of an imaging capsule that scans the intestine using X-rays and collects data that is converted by the system software into a three dimensional reconstructed image of the large intestine. The capsule is carried through the digestive system by its natural motility, and displays data that enable imaging of the colon and detection of clinically significant polyps with a high degree of sensitivity.